相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice
Rui Tada et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Lipid-Based Particles: versatile Delivery Systems for Mucosal vaccination against infection
Blaise Corthesy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Polymeric Caffeic Acid Is a Safer Mucosal Adjuvant That Augments Antigen-Specific Mucosal and Systemic Immune Responses in Mice
Rui Tada et al.
MOLECULAR PHARMACEUTICS (2018)
Development of a nanogel-based nasal vaccine as a novel antigen delivery system
Rika Nakahashi-Ouchida et al.
EXPERT REVIEW OF VACCINES (2017)
Modes of Action for Mucosal Vaccine Adjuvants
Taiki Aoshi
VIRAL IMMUNOLOGY (2017)
The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants
Sae-Hae Kim et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2017)
Species difference in reactivity to lignin-like enzymatically polymerized polyphenols on interferon-γ synthesis and involvement of interleukin-2 production in mice
Daisuke Yamanaka et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Advances and challenges in mucosal adjuvant technology
Daniel Newsted et al.
VACCINE (2015)
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine
Hidehiko Suzuki et al.
PLOS ONE (2015)
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice
Rui Tada et al.
PLOS ONE (2015)
Antibacterial Activity of Polyphenols
Erika Coppo et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
The Development of Mucosal Vaccine Using Bacterial Function for Targeting Mucosal Tissues
Hidehiko Suzuki et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2014)
Effect of polymeric caffeic acid on antitumour activity and natural killer cell activity in mice
Daisuke Yamanaka et al.
JOURNAL OF FUNCTIONAL FOODS (2014)
Modulation of interferon-γ synthesis by the effects of lignin-like enzymatically polymerized polyphenols on antigen-presenting cell activation and the subsequent cell-to-cell interactions
Daisuke Yamanaka et al.
FOOD CHEMISTRY (2013)
Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
Il Gyu Kong et al.
INFECTION AND IMMUNITY (2013)
Interactions between Polyphenols and Macromolecules: Quantification Methods and Mechanisms
C. Le Bourvellec et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2012)
The Effect of Enzymatically Polymerised Polyphenols on CD4 Binding and Cytokine Production in Murine Splenocytes
Daisuke Yamanaka et al.
PLOS ONE (2012)
Mucosal vaccine adjuvants update
Joon Haeng Rhee et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2012)
Mucosal Immunity and Candida albicans Infection
David L. Moyes et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China
Guilan Lu et al.
VIROLOGY JOURNAL (2011)
TLR4 Signaling Inhibitory Pathway Induced by Green Tea Polyphenol Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor
Eui Hong Byun et al.
JOURNAL OF IMMUNOLOGY (2010)
Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers
Olga Borges et al.
PHARMACEUTICAL RESEARCH (2010)
Involvement of Branched Units at Position 6 in the Reactivity of a Unique Variety of β-D-Glucan from Aureobasidium pullulans to Antibodies in Human Sera
Rui Tada et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2009)
Green tea Polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor
Daisuke Umeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?
Jiri Mestecky et al.
JOURNAL OF IMMUNOLOGY (2007)
Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine
Jun Kunisawa et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2007)
Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases
AS Fauci et al.
EMERGING INFECTIOUS DISEASES (2005)
Immune response versus mucosal tolerance to mucosally administered antigens
J Mestecky et al.
VACCINE (2005)
Mucosa-associated lymphoid tissues in the aerodigestive tract: Their shared and divergent traits and their importance to the orchestration of the mucosal immune system
J Kunisawa et al.
CURRENT MOLECULAR MEDICINE (2005)
A receptor for green tea polyphenol EGCG
H Tachibana et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2
AE Gillgrass et al.
JOURNAL OF VIROLOGY (2003)
Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier
F Zhou et al.
BIOSCIENCE REPORTS (2002)
Polyphenol/peptide binding and precipitation
AJ Charlton et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Infectious diseases: Considerations for the 21st century
AS Fauci
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
